Home > National Drug Code (NDC) > Zafirlukast

Zafirlukast - 55111-626-30 - (Zafirlukast)

Alphabetical Index


Drug Information of Zafirlukast

Product NDC: 55111-626
Proprietary Name: Zafirlukast
Non Proprietary Name: Zafirlukast
Active Ingredient(s): 20    mg/1 & nbsp;   Zafirlukast
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Zafirlukast

Product NDC: 55111-626
Labeler Name: Dr. Reddys Laboratories Limited
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090372
Marketing Category: ANDA
Start Marketing Date: 20101118

Package Information of Zafirlukast

Package NDC: 55111-626-30
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (55111-626-30)

NDC Information of Zafirlukast

NDC Code 55111-626-30
Proprietary Name Zafirlukast
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (55111-626-30)
Product NDC 55111-626
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Zafirlukast
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20101118
Marketing Category Name ANDA
Labeler Name Dr. Reddys Laboratories Limited
Substance Name ZAFIRLUKAST
Strength Number 20
Strength Unit mg/1
Pharmaceutical Classes Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]

Complete Information of Zafirlukast


General Information